222 related articles for article (PubMed ID: 32425818)
21. In vitro pharmacological evaluation of multitarget agents for thromboxane prostanoid receptor antagonism and COX-2 inhibition.
Hoxha M; Buccellati C; Capra V; Garella D; Cena C; Rolando B; Fruttero R; Carnevali S; Sala A; Rovati GE; Bertinaria M
Pharmacol Res; 2016 Jan; 103():132-43. PubMed ID: 26621246
[TBL] [Abstract][Full Text] [Related]
22. Neuroinflammation in Obsessive-Compulsive Disorder: Sydenham Chorea, Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections, and Pediatric Acute Onset Neuropsychiatric Syndrome.
Vreeland A; Thienemann M; Cunningham M; Muscal E; Pittenger C; Frankovich J
Psychiatr Clin North Am; 2023 Mar; 46(1):69-88. PubMed ID: 36740356
[TBL] [Abstract][Full Text] [Related]
23. The neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in adolescent obsessive-compulsive disorder: Does comorbid anxiety disorder affect inflammatory response?
Özyurt G; Binici NC
Psychiatry Res; 2019 Feb; 272():311-315. PubMed ID: 30597382
[TBL] [Abstract][Full Text] [Related]
24. Meloxicam inhibits prostaglandin E(2) generation via cyclooxygenase 2 in the inflammatory site but not that via cyclooxygenase 1 in the stomach.
Ogino K; Hatanaka K; Kawamura M; Ohno T; Harada Y
Pharmacology; 2000 Nov; 61(4):244-50. PubMed ID: 11093076
[TBL] [Abstract][Full Text] [Related]
25. Maternal autoimmunity and inflammation are associated with childhood tics and obsessive-compulsive disorder: Transcriptomic data show common enriched innate immune pathways.
Jones HF; Han VX; Patel S; Gloss BS; Soler N; Ho A; Sharma S; Kothur K; Nosadini M; Wienholt L; Hardwick C; Barnes EH; Lim JR; Alshammery S; Nielsen TC; Wong M; Hofer MJ; Nassar N; Gold W; Brilot F; Mohammad SS; Dale RC
Brain Behav Immun; 2021 May; 94():308-317. PubMed ID: 33422639
[TBL] [Abstract][Full Text] [Related]
26. Cyclooxygenase-2 Inhibitors as a Therapeutic Target in Inflammatory Diseases.
Ferrer MD; Busquets-Cortés C; Capó X; Tejada S; Tur JA; Pons A; Sureda A
Curr Med Chem; 2019; 26(18):3225-3241. PubMed ID: 29756563
[TBL] [Abstract][Full Text] [Related]
27. Inflammation in Tic Disorders and Obsessive-Compulsive Disorder: Are PANS and PANDAS a Path Forward?
Gilbert DL
J Child Neurol; 2019 Sep; 34(10):598-611. PubMed ID: 31111754
[TBL] [Abstract][Full Text] [Related]
28. Genetic variant of cyclooxygenase-2 in gastric cancer: More inflammation and susceptibility.
Ji XK; Madhurapantula SV; He G; Wang KY; Song CH; Zhang JY; Wang KJ
World J Gastroenterol; 2021 Jul; 27(28):4653-4666. PubMed ID: 34366627
[TBL] [Abstract][Full Text] [Related]
29. Anti-inflammatory drugs: new multitarget compounds to face an old problem. The dual inhibition concept.
Celotti F; Laufer S
Pharmacol Res; 2001 May; 43(5):429-36. PubMed ID: 11394934
[TBL] [Abstract][Full Text] [Related]
30. Neuroprotection of cultured cortical neurons mediated by the cyclooxygenase-2 inhibitor APHS can be reversed by a prostanoid.
Carlson NG
J Neurosci Res; 2003 Jan; 71(1):79-88. PubMed ID: 12478616
[TBL] [Abstract][Full Text] [Related]
31. Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implications.
Pairet M; Engelhardt G
Fundam Clin Pharmacol; 1996; 10(1):1-17. PubMed ID: 8900495
[TBL] [Abstract][Full Text] [Related]
32. Anti-Inflammatory Therapy as a Promising Target in Neuropsychiatric Disorders.
Ballaz S; Bourin M
Adv Exp Med Biol; 2023; 1411():459-486. PubMed ID: 36949322
[TBL] [Abstract][Full Text] [Related]
33. Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs.
Giuliano F; Warner TD
Br J Pharmacol; 1999 Apr; 126(8):1824-30. PubMed ID: 10372826
[TBL] [Abstract][Full Text] [Related]
34. Does obsessive-compulsive personality disorder belong within the obsessive-compulsive spectrum?
Fineberg NA; Sharma P; Sivakumaran T; Sahakian B; Chamberlain SR
CNS Spectr; 2007 Jun; 12(6):467-82. PubMed ID: 17545957
[TBL] [Abstract][Full Text] [Related]
35. The second generation of COX-2 inhibitors: what advantages do the newest offer?
Stichtenoth DO; Frölich JC
Drugs; 2003; 63(1):33-45. PubMed ID: 12487621
[TBL] [Abstract][Full Text] [Related]
36. Preferential and non-selective cyclooxygenase inhibitors reduce inflammation during lipopolysaccharide-induced synovitis.
Morton AJ; Campbell NB; Gayle JM; Redding WR; Blikslager AT
Res Vet Sci; 2005 Apr; 78(2):189-92. PubMed ID: 15563928
[TBL] [Abstract][Full Text] [Related]
37. [Pharmacology of cyclooxygenase 2 inhibition].
Beubler E
Wien Med Wochenschr; 2003; 153(5-6):95-9. PubMed ID: 12705061
[TBL] [Abstract][Full Text] [Related]
38. Refractory obsessive-compulsive disorder with symptoms regressing after thalamic infarction: A case report.
Erbay LG; Erbay MF; Kamışlı S; Demirbay S; Ünal S
Neurol India; 2022; 70(1):399-401. PubMed ID: 35263927
[TBL] [Abstract][Full Text] [Related]
39. Non-steroidal anti-inflammatory drugs and cyclooxygenase in Alzheimer's disease.
Hoozemans JJ; Veerhuis R; Rozemuller AJ; Eikelenboom P
Curr Drug Targets; 2003 Aug; 4(6):461-8. PubMed ID: 12866660
[TBL] [Abstract][Full Text] [Related]
40. Advances in the neurobiology of obsessive-compulsive disorder. Implications for conceptualizing putative obsessive-compulsive and spectrum disorders.
Stein DJ
Psychiatr Clin North Am; 2000 Sep; 23(3):545-62. PubMed ID: 10986727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
